Healthcare · Pharmaceutical expenditure

Pharmaceutical expenditure in Sweden in 2026

Sweden's pharmaceutical expenditure stands at 1.18 % GDP of GDP in 2026 — a moderate figure reflecting a balanced drug policy. The Nordic healthcare model emphasises prevention and rational prescribing, keeping costs in check without compromising quality. Meanwhile, the country fosters a strong biopharma sector: clusters around Uppsala and Lund are among Europe's leading hubs for innovative drug development. Sweden ranks 101 out of 197 in this indicator.

Data for 2026 · unit: % GDP
Position

Sweden world ranking

#101 / 197

Country position on the scale from last to first place for this indicator.

SE
#101
#197#1
Trend

Change over time

Change in indicator over the available period.

1.10
1990
1.30
2000
1.20
2010
1.15
2020
1.18
2026

Values — % GDP

Related questions

People also search for

Other pages of the reference by this indicator.

Summary

Frequently asked questions

Pharmaceutical expenditure in Sweden — how much?
Based on 2026 data — 1.18 % GDP. This is rank #101 out of 197 countries.
What is Sweden's rank by Pharmaceutical expenditure?
Sweden ranks #101 out of 197 countries in the world ranking by «Pharmaceutical expenditure».
How has Pharmaceutical expenditure changed in Sweden?
Over the available period the indicator changed from 1.10 to 1.18 % GDP.